Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201807735986564Not yet recruiting
Randomised trial of bupivacaine in None (2 arms), sponsored by Pireshin Ramdharee Professional Corporation. Primary endpoint: Sensory level achieved. Planned start Jul 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201807735986564.